SEC Form 4 · accession 0001209191-17-051250
bluebird bio, Inc. · BLUE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel Lynch
Director
Period of report
Aug 31, 2017
Accepted (ET)
Sep 5, 2017 · 4:01 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001293971
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 31, 2017 | M | 500 | $5.5004 | A | 3,300 | D | |
| Common Stock | Aug 31, 2017 | S | 500 | $120.00 | D | 2,800 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2 | $5.5004 | Aug 31, 2017 | M | 500 | D | — | Jan 16, 2023 | Common Stock | 500 | 23,342 | D |
Explanation of responses
- F1This sales reported in the Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on December 14, 2016.
- F2This option vests over a four-year period at a rate of twenty-five percent (25%) on January 16, 2014 in 36 equal monthly installments thereafter.